Myocardial infarction in elderly patients: How to assess their bleeding risk?

Thomas Kietzmann

doi:10.1160/TH15-06-0507

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2015; 114(05): 869-871
DOI: 10.1160/TH15-06-0507

Invited Editorial Focus

Schattauer GmbH

Myocardial infarction in elderly patients: How to assess their bleeding risk?

Authors

Thomas Kietzmann

¹Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland

Abstract

Full Text

References

References
1 Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol 2011; 8: 140-147.
2 Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
3 Lee PY, Alexander KP, Hammill BG. et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. J Am Med Assoc 2001; 286: 708-713.
4 Melgarejo-Moreno A, Galcera-Tomas J, Garcia-Al-berola A. et al. Clinical and prognostic characteristics associated with age and gender in acute myocardial infarction: a multihospital perspective in the Murcia region of Spain. Eur J Epidemiol 1999; 15: 621-629.
5 Yan RT, Yan AT, Tan M. et al. Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J 2006; 151: 352-359.
6 Alexander KP, Newby LK, Armstrong PW. et al. Acute coronary care in the elderly, part II: ST-segment elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115: 2570-2589.
7 Alexander KP, Newby LK, Cannon CP. et al. Acute coronary care in the elderly, part I: Non ST-segment elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115: 2549-2569.
8 Modi KA, Nylk TM, Sheridan FM. Medical management of acute ST elevation myocardial infarction. J La State Med Soc 2001; 153: 284-290.
9 Ohman EM, Harrington RA, Cannon CP. et al. Intravenous thrombolysis in acute myocardial infarction. Chest 2001; 119 (1 Suppl) 253S-277S.
10 Weaver WD, Simes RJ, Betriu A. et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. J Am Med Assoc 1997; 278: 2093-2098.
11 Berger AK, Schulman KA, Gersh BJ. et al. Primary coronary angioplasty vs thrombolytics for the management of acute myocardial infarction in elderly patients. J Am Med Assoc 1999; 282: 341-348.
12 Ribeiro EE, Silva LA, Carneiro R. et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376-380.
13 Grinfeld L, Berrocal D, Bellardi J. et al. Fibrinolytics versus primary angioplasty in acute myocardial infarction. J Am Coll Cardiol 1996; 27: A222
14 Zijlstra F, Beukema WP, van ’t Hof AW. et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. JACC 1997; 29: 958-1012.
15 Ribichini F, Steffenino G, Dellavalle A. et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST depressionCa single-center randomized study. J Am Coll Cardiol 1996; 27: A221
16 Garcia E, Elizaga J, Soriano J. Primary angioplasty versus thrombolysis with t-PA in the anterior myocardial infarction. J Am Coll Cardiol 1997; 29: A-389
17 Van de Werf F, Bax J, Betriu A. et al. ESC Committee for Practice Guidelines (CPG) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945.
18 Antman EM, Anbe DT, Armstrong PW. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004; 44: 671-719.
19 Kushner FG, Hand M, Smith Jr SC. et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-2241.
20 Moscucci M, Fox KA, Cannon CP. et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
21 Marso SP, Amin AP, House JA. et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. J Am Med Assoc 2010; 303: 2156-2164.
22 Ndrepepa G, Berger PB, Mehilli J. et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 2008; 51: 690-697.
23 Chhatriwalla AK, Amin AP, Kennedy KF. et al. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. J Am Med Assoc 2013; 309: 1022-1029.
24 Rao SV, Dai D, Subherwal S. et al. Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients. JACC Cardiovasc Interv 2012; 5: 958-965.
25 Marso SP, Amin AP, House JA. et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. J Am Med Assoc 2010; 303: 2156-2164.
26 Ariza-Sole A, Salazar-Mendiguchia J, Lorente V. et al. Predictive ability of bleeding risk scores in the routine clinical practice. Eur Heart J Acute Cardiovasc Care. 2014 Epub ahead of print.
27 Abu-Assi E, Raposeiras-Roubin S, Lear P. et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2012; 1: 222-231.
28 Ariza-Sole A, Formiga F, Lorente V. et al. Efficacy of bleeding risk scores in elderly patients with acute coronary syndromes. Rev Esp Cardiol 2014; 67: 463-470.
29 Faustino A, Mota P, Silva J. Non-ST-elevation acute coronary syndromes in octogenarians: Applicability of the GRACE and CRUSADE scores. Rev Port Cardiol. 2014 Epub ahead of print
30 Koller L, Rothgerber DJ, Sulzgruber P. et al. History of previous bleeding and C-reactive protein improve assessment of bleeding risk in elderly patients (> 80 years) with myocardial infarction. Thromb Haemost 2015; 114: 1085-1091.
31 Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
32 Mehran R, Rao SV, Bhatt DL. et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
33 Aradi D, Collet JP, Mair J. et al. Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association of the European Society of Cardiology; Working Group on Thrombosis of the European Society of Cardiology. Platelet function testing in acute cardiac care – is there a role for prediction or prevention of stent thrombosis and bleeding?. Thromb Haemost 2015; 113: 221-230.
34 De Luca G, Navarese E, Marino P. Risk profile and benefits from Gp Ilb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J 2009; 30: 2705-2713.
35 Alexopoulos D, Stavrou K, Koniari I. et al. Ticagrelor vs prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events. Thromb Haemost 2014; 112: 551-557.